The fellowship is filled for academic years 2019-2020 and 2020-2021 but applications are now being considered for 2021-2022 and beyond.
Although we participate in the Society for Hematopathology guidelines for fellowship application submission (applications are accepted until December 31, 19 months in advance of the start date, e.g., December 31, 2019 for the 2021-2022 fellowship, interviews start that January and decisions announced in February and beyond), we also recognize that it may be more convenient to interview earlier and remain open to inquiries at any time.
We also encourage those interested in our program to apprise us of that interest up to several years in advance, especially for those who may be oriented toward the physician-scientist track, since this requires coordination with research programs in individual laboratories.
The ACGME-accredited Hematopathology Fellowship training program at Yale New Haven Medical Center and the Veterans Administration Connecticut Medical Center is designed to provide a comprehensive experience in all aspects of hematopathology including consultative clinical practice, state-of-the-art diagnostic testing, multi-level teaching and an understanding of the principles of biomedical research.
Instruction and practical experience occurs for all aspects of hematolopathology: lymphoid and myeloid disorders including lymph node, bone marrow, peripheral blood and other tissue review, pediatric hematopathology, coagulopathies and red cell disorders. The program takes advantage of the rich environment in both anatomic and clinical pathology at these institutions with a special emphasis on integrating all aspects of clinical practice, teaching and research with the other academic activities in Pathology and Laboratory Medicine at Yale. In addition, the program coordinates on a day to day basis with the extensive clinical and investigative activities of the sections of Medicine Hematology, Medical Oncology and the Yale Cancer Center, the Pediatric Hematology-Oncology section, the Yale Stem Cell program, and the Human Translational Immunology Program.
The program especially highlights the modern need to fully integrate morphology, immunophenotyping, flow cytometry, cytogenetics, molecular diagnostics, functional cellular and protein assays, and longitudinal clinical correlation in providing a complete hematopathology consultation that is maximally useful in both establishing a patient's initial diagnosis/prognosis, and in monitoring the efficacy of therapeutic interventions. The trainee gains hands-on experience in all these areas with an emphasis on coordinating the results of different technologies.
The program envisions our trainees, and all hematopathologists, as being the central consultative core of the diagnostic and therapeutic team caring for patients with hematologic disease, both benign and malignant. Close communication with internal medicine, surgery, ob/gyn and pediatric colleagues is emphasized; the fellow provides formal written consultative interpretation not only for lymph node, blood, tissue and bone marrow specimens but also for coagulation and hemoglobinopathy testing. Hands-on experience in relevant bedside procedures is a formal part of the program.
Finally, the program accepts as a given that the hematopathologist in clinical practice must also be an excellent teacher and communicator - hence the fellow is given significant responsibility for presenting at multidisciplinary conferences.
Moreover, we believe that an hematopathologist should be able to understand and bring to his/her practice cutting edge diagnostic modalities that pass the test of "evidence-based" medical practice. Toward this end, the program provides training in some of the principles of state-of-the-art basic, clinical and translational research through active participation in a journal club, by providing for attendance at a national meeting, and by having the trainee carry out at least one significant clinically-oriented research project during their year of clinical training.